2023 Belgium Anemia Diagnostic Testing Market Assessment-2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities

June 2023 | | ID: 266FAD36B634EN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source, including:

• 2022 Supplier Sales and Shares by Segment and Test
• 2022-2027 Volume and Sales Segment Forecasts by Test
• Supplier Strategies and SWOT Analysis
• Instrumentation Pipeline
• Emerging Technologies
• Opportunities for New Analyzers and Consumables
• Market Challenges and Risks

The report provides test volume and sales forecasts by market segment for the following assays:

CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D

The report is available by section, and can be customized to specific information needs and budget.

Rationale

During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

Contents

INTRODUCTION

WORLDW IDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Anemia Diagnostics Tests
The report provides segment test volume and sales forecasts for the following tests: CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, and Vitamin D.
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alfa W assermann, AMS, Awareness Technologies, Beckman Coulter, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens Healthineers, Tosoh, Vital Diagnostics and other suppliers.
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Chemiluminescence
    c. Enzyme Immunoassays
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors

TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
IL/Werfen
Table of Contents (Continued)
Kyowa Medex
PerkinElmer
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh